Annual Total Liabilities
$49.18 M
+$11.72 M+31.30%
December 31, 2023
Summary
- As of March 6, 2025, ABEO annual total liabilities is $49.18 million, with the most recent change of +$11.72 million (+31.30%) on December 31, 2023.
- During the last 3 years, ABEO annual total liabilities has risen by +$529.00 thousand (+1.09%).
- ABEO annual total liabilities is now at all-time high.
Performance
ABEO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$74.82 M
+$14.06 M+23.13%
September 30, 2024
Summary
- As of March 6, 2025, ABEO quarterly total liabilities is $74.82 million, with the most recent change of +$14.06 million (+23.13%) on September 30, 2024.
- Over the past year, ABEO quarterly total liabilities has stayed the same.
- ABEO quarterly total liabilities is now -10.62% below its all-time high of $83.71 million, reached on March 31, 2024.
Performance
ABEO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ABEO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.3% | 0.0% |
| 3 y3 years | +1.1% | +90.5% |
| 5 y5 years | +21.9% | +60.1% |
ABEO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.1% | -10.6% | +220.4% |
| 5 y | 5-year | at high | +32.1% | -10.6% | +220.4% |
| alltime | all time | at high | >+9999.0% | -10.6% | >+9999.0% |
Abeona Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $74.82 M(+23.1%) |
| Jun 2024 | - | $60.76 M(-27.4%) |
| Mar 2024 | - | $83.71 M(+70.2%) |
| Dec 2023 | $49.18 M(+31.3%) | $49.18 M(+11.6%) |
| Sep 2023 | - | $44.05 M(-0.4%) |
| Jun 2023 | - | $44.20 M(+27.7%) |
| Mar 2023 | - | $34.60 M(-7.6%) |
| Dec 2022 | $37.45 M(+0.6%) | $37.45 M(+60.4%) |
| Sep 2022 | - | $23.35 M(-5.2%) |
| Jun 2022 | - | $24.63 M(+3.8%) |
| Mar 2022 | - | $23.73 M(-36.2%) |
| Dec 2021 | $37.22 M(-23.5%) | $37.22 M(-5.2%) |
| Sep 2021 | - | $39.27 M(-15.7%) |
| Jun 2021 | - | $46.59 M(-1.0%) |
| Mar 2021 | - | $47.04 M(-3.3%) |
| Dec 2020 | $48.65 M(+8.2%) | $48.65 M(+9.9%) |
| Sep 2020 | - | $44.25 M(+2.1%) |
| Jun 2020 | - | $43.32 M(+1.6%) |
| Mar 2020 | - | $42.63 M(-5.2%) |
| Dec 2019 | $44.95 M(+11.4%) | $44.95 M(-3.8%) |
| Sep 2019 | - | $46.72 M(-10.6%) |
| Jun 2019 | - | $52.25 M(+8.1%) |
| Mar 2019 | - | $48.34 M(+19.8%) |
| Dec 2018 | $40.35 M(+365.6%) | $40.35 M(+290.6%) |
| Sep 2018 | - | $10.33 M(+78.6%) |
| Jun 2018 | - | $5.78 M(-10.4%) |
| Mar 2018 | - | $6.45 M(-25.5%) |
| Dec 2017 | $8.67 M(-27.5%) | $8.67 M(+48.1%) |
| Sep 2017 | - | $5.85 M(-22.8%) |
| Jun 2017 | - | $7.58 M(-20.8%) |
| Mar 2017 | - | $9.58 M(-19.9%) |
| Dec 2016 | $11.96 M(-3.0%) | $11.96 M(+15.8%) |
| Sep 2016 | - | $10.33 M(-18.5%) |
| Jun 2016 | - | $12.67 M(+7.8%) |
| Mar 2016 | - | $11.76 M(-4.7%) |
| Dec 2015 | $12.33 M(+4.8%) | $12.33 M(-25.1%) |
| Sep 2015 | - | $16.48 M(-2.9%) |
| Jun 2015 | - | $16.98 M(+70.5%) |
| Mar 2015 | - | $9.96 M(-15.4%) |
| Dec 2014 | $11.77 M(-23.6%) | $11.77 M(-61.6%) |
| Sep 2014 | - | $30.64 M(+7.0%) |
| Jun 2014 | - | $28.64 M(+79.3%) |
| Mar 2014 | - | $15.97 M(+3.8%) |
| Dec 2013 | $15.39 M(-18.2%) | $15.39 M(+8.0%) |
| Sep 2013 | - | $14.26 M(-3.3%) |
| Jun 2013 | - | $14.75 M(-3.8%) |
| Mar 2013 | - | $15.33 M(-18.5%) |
| Dec 2012 | $18.81 M(-12.1%) | $18.81 M(-60.4%) |
| Sep 2012 | - | $47.52 M(+41.8%) |
| Jun 2012 | - | $33.51 M(+43.5%) |
| Mar 2012 | - | $23.36 M(+9.2%) |
| Dec 2011 | $21.39 M | $21.39 M(-16.7%) |
| Sep 2011 | - | $25.69 M(-11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | - | $29.00 M(-1.9%) |
| Mar 2011 | - | $29.58 M(+0.0%) |
| Dec 2010 | $29.57 M(+3.5%) | $29.57 M(-9.7%) |
| Sep 2010 | - | $32.73 M(+51.5%) |
| Jun 2010 | - | $21.60 M(-15.4%) |
| Mar 2010 | - | $25.52 M(-10.7%) |
| Dec 2009 | $28.57 M(+86.1%) | $28.57 M(+56.1%) |
| Sep 2009 | - | $18.30 M(+13.1%) |
| Jun 2009 | - | $16.18 M(+3.7%) |
| Mar 2009 | - | $15.59 M(+1.5%) |
| Dec 2008 | $15.36 M(+81.4%) | $15.36 M(+20.3%) |
| Sep 2008 | - | $12.77 M(+16.1%) |
| Jun 2008 | - | $10.99 M(+25.2%) |
| Mar 2008 | - | $8.78 M(+3.7%) |
| Dec 2007 | $8.47 M(-48.1%) | $8.47 M(-59.1%) |
| Sep 2007 | - | $20.69 M(+8.1%) |
| Jun 2007 | - | $19.14 M(+2.9%) |
| Mar 2007 | - | $18.60 M(+14.0%) |
| Dec 2006 | $16.31 M(+42.5%) | $16.31 M(-23.3%) |
| Sep 2006 | - | $21.27 M(+3.7%) |
| Jun 2006 | - | $20.51 M(+4.9%) |
| Mar 2006 | - | $19.55 M(+70.7%) |
| Dec 2005 | $11.45 M(-35.5%) | $11.45 M(-45.3%) |
| Sep 2005 | - | $20.95 M(-2.6%) |
| Jun 2005 | - | $21.51 M(+5.9%) |
| Mar 2005 | - | $20.32 M(+14.5%) |
| Dec 2004 | $17.75 M(+0.7%) | $17.75 M(+1.7%) |
| Sep 2004 | - | $17.46 M(+0.8%) |
| Jun 2004 | - | $17.32 M(-1.3%) |
| Mar 2004 | - | $17.54 M(-0.5%) |
| Dec 2003 | $17.64 M(-7.2%) | $17.64 M(+6.6%) |
| Sep 2003 | - | $16.54 M(-6.5%) |
| Jun 2003 | - | $17.68 M(-5.0%) |
| Mar 2003 | - | $18.62 M(-2.0%) |
| Dec 2002 | $19.00 M(+15.8%) | $19.00 M(+10.4%) |
| Sep 2002 | - | $17.21 M(+0.0%) |
| Jun 2002 | - | $17.21 M(+0.9%) |
| Mar 2002 | - | $17.06 M(+3.9%) |
| Dec 2001 | $16.41 M(+5.7%) | $16.41 M(+3.8%) |
| Sep 2001 | - | $15.81 M(+2.4%) |
| Jun 2001 | - | $15.43 M(+0.3%) |
| Mar 2001 | - | $15.39 M(-0.9%) |
| Dec 2000 | $15.52 M(+1452.2%) | $15.52 M(+2.3%) |
| Sep 2000 | - | $15.18 M(+928.5%) |
| Jun 2000 | - | $1.48 M(-66.5%) |
| Mar 2000 | - | $4.41 M(+340.9%) |
| Dec 1999 | $1.00 M(+66.7%) | $1.00 M(+7.5%) |
| Sep 1999 | - | $930.00 K(+27.2%) |
| Jun 1999 | - | $731.00 K(+10.1%) |
| Mar 1999 | - | $664.00 K |
| Dec 1998 | $600.00 K(-29.2%) | - |
| Dec 1997 | $848.00 K(-2.3%) | - |
| Dec 1996 | $868.00 K(+95.9%) | - |
| Dec 1995 | $443.00 K | - |
FAQ
- What is Abeona Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Abeona Therapeutics?
- What is Abeona Therapeutics annual total liabilities year-on-year change?
- What is Abeona Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Abeona Therapeutics?
- What is Abeona Therapeutics quarterly total liabilities year-on-year change?
What is Abeona Therapeutics annual total liabilities?
The current annual total liabilities of ABEO is $49.18 M
What is the all time high annual total liabilities for Abeona Therapeutics?
Abeona Therapeutics all-time high annual total liabilities is $49.18 M
What is Abeona Therapeutics annual total liabilities year-on-year change?
Over the past year, ABEO annual total liabilities has changed by +$11.72 M (+31.30%)
What is Abeona Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ABEO is $74.82 M
What is the all time high quarterly total liabilities for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly total liabilities is $83.71 M
What is Abeona Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ABEO quarterly total liabilities has changed by $0.00 (0.00%)